Not available
Quote | Kissei Pharmaceuticals Co Ltd (OTCMKTS:KSPHF)
Last: | $19.322 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $19.322 |
High: | $0 |
Low: | $0 |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Kissei Pharmaceuticals Co Ltd (OTCMKTS:KSPHF)
Summary In terms of product sales, RIGL has been a one drug company with Tavalisse in immune thrombocytopenia. The recent approval of Rezlidhia opens the door for investors to track the growth of another drug, a new source of excitement. The potential for sales growth with Tavalisse...
Summary RIGL hoped to expand the label of its drug Tavalisse (fostamatinib), but the failure of the drug in phase 3 appeared to scupper its chances. RIGL sought guidance to see if a reanalysis of the failed phase 3 study might be well received, but it doesn't appear it was. Th...
Message Board Posts | Kissei Pharmaceuticals Co Ltd (OTCMKTS:KSPHF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |